Science Explorer Back to mapMap
Discussion
Company · Turin · Italy

Paladin Pharma (Italy)

Research works
13
▲ 419% vs 2018-21
Citations
238
18.8 per fractional work
Top-10% rate
9.3%
all institutions 10.0%
Open access
41%
world 40%
International
15%
world 18%

Not ranked overall: Paladin Pharma (Italy) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Paladin Pharma (Italy) work in?

In all years, 52% of research at Paladin Pharma (Italy) is in Health Sciences, 26% in Life Sciences. Its largest fields are Medicine (44%), Biochemistry, Genetics and Molecular Biology (14%), Economics, Econometrics and Finance (10%). It does 1.6× the world's share of Health Sciences.

Health Sciences: 7 fractional works · 52.0% of its workMedicine: 6 fractional works · 44.4% of its workHematology: 1 fractional works · 5.7% of its workEndocrinology, Diabetes and Metabolism: 1 fractional works · 5.3% of its workPhysiology: 1 fractional works · 4.8% of its workPharmacology: 0 fractional works · 4.0% of its workSurgery: 0 fractional works · 3.4% of its workImmunology and Allergy: 0 fractional works · 3.1% of its workCritical Care and Intensive Care Medicine: 0 fractional works · 2.6% of its workEmergency Medicine: 0 fractional works · 2.6% of its workFamily Practice: 0 fractional works · 2.6% of its workUrology: 0 fractional works · 2.6% of its workPulmonary and Respiratory Medicine: 0 fractional works · 2.4% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 1.3% of its workGeriatrics and Gerontology: 0 fractional works · 0.9% of its workInfectious Diseases: 0 fractional works · 0.9% of its workOncology: 0 fractional works · 0.9% of its workNephrology: 0 fractional works · 0.5% of its workGastroenterology: 0 fractional works · 0.3% of its workPathology and Forensic Medicine: 0 fractional works · 0.3% of its workRheumatology: 0 fractional works · 0.3% of its workHealth Professions: 0 fractional works · 2.8% of its workSpeech and Hearing: 0 fractional works · 1.5% of its workOccupational Therapy: 0 fractional works · 1.3% of its workNursing: 0 fractional works · 2.6% of its workNutrition and Dietetics: 0 fractional works · 2.6% of its workVeterinary: 0 fractional works · 2.2% of its workSmall Animals: 0 fractional works · 2.2% of its workLife Sciences: 3 fractional works · 26.1% of its workBiochemistry, Genetics and Molecular Biology: 2 fractional works · 13.8% of its workMolecular Biology: 1 fractional works · 5.7% of its workCell Biology: 1 fractional works · 5.3% of its workGenetics: 0 fractional works · 1.4% of its workCancer Research: 0 fractional works · 1.3% of its workNeuroscience: 1 fractional works · 7.9% of its workCellular and Molecular Neuroscience: 0 fractional works · 4.0% of its workEndocrine and Autonomic Systems: 0 fractional works · 4.0% of its workAgricultural and Biological Sciences: 0 fractional works · 2.6% of its workAnimal Science and Zoology: 0 fractional works · 1.3% of its workFood Science: 0 fractional works · 1.3% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 1.3% of its workPharmaceutical Science: 0 fractional works · 1.3% of its workImmunology and Microbiology: 0 fractional works · 0.5% of its workImmunology: 0 fractional works · 0.5% of its workPhysical Sciences: 1 fractional works · 11.2% of its workChemistry: 1 fractional works · 5.3% of its workAnalytical Chemistry: 0 fractional works · 2.6% of its workOrganic Chemistry: 0 fractional works · 2.6% of its workSmaller subfields together: 0 fractional works · 0.1% of its workMathematics: 1 fractional works · 5.3% of its workStatistics and Probability: 1 fractional works · 5.3% of its workMaterials Science: 0 fractional works · 0.6% of its workBiomaterials: 0 fractional works · 0.6% of its workSocial Sciences: 1 fractional works · 10.7% of its workEconomics, Econometrics and Finance: 1 fractional works · 10.0% of its workEconomics and Econometrics: 1 fractional works · 10.0% of its workSocial Sciences: 0 fractional works · 0.6% of its workSociology and Political Science: 0 fractional works · 0.6% of its workALL ITS WORKPaladin Pharma(Italy)13fractional works, all years
Life Sciences26%Physical Sciences11%Health Sciences52%Social Sciences11%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 14 fields, with their numbers
    1. Medicine644.4%
    2. Health Professions02.8%
    3. Nursing02.6%
    4. Veterinary02.2%
    1. Biochemistry, Genetics and Molecular Biology213.8%
    2. Neuroscience17.9%
    3. Agricultural and Biological Sciences02.6%
    4. Pharmacology, Toxicology and Pharmaceutics01.3%
    5. Immunology and Microbiology00.5%
    1. Chemistry15.3%
    2. Mathematics15.3%
    3. Materials Science00.6%
    1. Economics, Econometrics and Finance110.0%
    2. Social Sciences00.6%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 1.60× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 1.26× its world share, 0 worksBiochemistry, Geneti…Mathematics: 12.92× its world share, 1 worksMathematicsHealth Professions: 0.16× its world share, 0 worksHealth ProfessionsMedicine: 1.32× its world share, 1 worksMedicineNursing: 15.51× its world share, 0 worksNursingVeterinary: 46.61× its world share, 0 worksVeterinaryEconomics, Econometrics and Finance: 13.50× its world share, 1 worksEconomics, Econometr…Social Sciences: 0.14× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Veterinary, 46.6×. Every wedge is a field page.

All 9 fields, with their numbers
  1. Veterinary46.61×0 works
  2. Nursing15.51×0 works
  3. Economics, Econometrics and Finance13.50×1 works
  4. Mathematics12.92×1 works
  5. Agricultural and Biological Sciences1.60×0 works
  6. Medicine1.32×1 works
  7. Biochemistry, Genetics and Molecular Biology1.26×0 works
  8. Health Professions0.16×0 works
  9. Social Sciences0.14×0 works

What are the most cited papers from Paladin Pharma (Italy)?

The most cited paper from Paladin Pharma (Italy) is "Enhancement of mitochondrial biogenesis with polyphenols: combined effects of resveratrol and equol in human endothelial cells" (Sergio Davinelli, Nadia Sapere, Manuela Visentin et al., 2013), with 76 citations. Next come "Preparation and characterization of cyclodextrin nanosponges for organic toxic molecule removal" (59) and "Platelet-Activating Factor-Induced Endothelial Cell Expression of Adhesion Molecules and Modulation of Surface Glycocalyx, Evaluated by Electron Spectroscopy for Chemical Analysis" (38).

Most cited papers
#PaperReleasedCitations
1 Enhancement of mitochondrial biogenesis with polyphenols: combined effects of resveratrol and equol in human endothelial cells Sergio Davinelli, Nadia Sapere, Manuela Visentin et al. · Immunity & Ageing Open access 11 Jul 2013 76
2 Preparation and characterization of cyclodextrin nanosponges for organic toxic molecule removal Cem Varan, Anastasia Anceschi, Serhat Sevli et al. · International Journal of Pharmaceutics Open access Jun 2020 59
3 Platelet-Activating Factor-Induced Endothelial Cell Expression of Adhesion Molecules and Modulation of Surface Glycocalyx, Evaluated by Electron Spectroscopy for Chemical Analysis Luigi Silvestro, Ruikun Chen, Françoise Sommer et al. · Seminars in Thrombosis and Hemostasis Apr 1994 38
4 Development of a high-performance liquid chromatographic—mass spectrometric technique, with an ionspray interface, for the determination of platelet-activating factor (PAF) and lyso-PAF in biological samples Luigi Silvestro, Raffaella Da Col, Ermanno Scappaticci et al. · Journal of Chromatography A Sep 1993 30
5 Characterization of the chemical structure of sulphated glycosaminoglycans after enzymatic digestion Raffaella Da Col, Luigi Silvestro, Annamaria Naggi et al. · Journal of Chromatography A Sep 1993 28
All 8 most cited papers, with filters and sorting

Which research topics does Paladin Pharma (Italy) publish most on?

By volume in 2022-now: Health Systems, Economic Evaluations, Quality of Life, Pharmaceutical Economics and Policy, Veterinary Medicine and Surgery and Statistical Methods in Clinical Trials.

  1. 1 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 1 works
  2. 2 Pharmaceutical Economics and Policy Economics and Econometrics 0 works
  3. 3 Veterinary Medicine and Surgery Small Animals 0 works
  4. 4 Statistical Methods in Clinical Trials Statistics and Probability 0 works
  5. 5 Medication Adherence and Compliance Family Practice 0 works
  6. 6 Advanced Causal Inference Techniques Statistics and Probability 0 works
  7. 7 Polysaccharides Composition and Applications Food Science 0 works
  8. 8 Animal Virus Infections Studies Animal Science and Zoology 0 works
  9. 9 Clinical Nutrition and Gastroenterology Nutrition and Dietetics 0 works
  10. 10 Food composition and properties Nutrition and Dietetics 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available41.3%not open58.7%

World: 40% of research is openly available.

with international co-authors15.4%domestic only84.6%

World: 18% is written across borders.

How has Paladin Pharma (Italy)'s research output changed?

Output in 2022-2025 was 419% higher than in 2018-2021.

still counting200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Paladin Pharma (Italy) as a percentage of every work published that year, 0.0000036% in 2024.

still counting0.00020%0.00040%Paladin Pharma (Italy)0.000054% in 2025200020102020

Fractional works of Paladin Pharma (Italy) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Turin

All research institutions in Turin

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Paladin Pharma (Italy). Posts are plain text and can be reported.